Autopsy report · NCT03869684
A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
Cause of deathSafety
“The study terminated for safety reasons”
Life of this trial
- Ran for about 1 year 2 months before it stopped.
- 13 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Sponsor type
- Industry
- Conditions
- Age-related Macular Degeneration
- Interventions
- MT-0814; Placebo
- Participants
- 13
- Sites
- 13
- Countries
- United States
Trials that died the same way
- Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
“Study was terminated due to safety reason.” - Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
“The study was terminated due to administrative, non-safety related reasons.” - Randomized Controlled Study to Incentivize Doctors for Appropriate Use of Medical Care in NL
“The study was terminated due to logistical reasons” - Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
“The study was terminated in the interest of patient safety.” - Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
“This study was terminated for reasons not related to efficacy or safety”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.